SCHEMBL5199137

SCHEMBL5199137

CC(C)n1sc(-c2ccccc2)c(NC2CCN(c3nccc(C(F)(F)F)n3)CC2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.46
RBP4 P02753 1/20 0.44
PKM P14618 2/20 0.42
CHRM4 P08173 1/20 0.40
LCAT P04180 1/20 0.40
ADRB1 P08588 1/20 0.39
ACACB O00763 2/20 0.39
HPGD P15428 1/20 0.39
CCR2 P41597 2/20 0.39
KCNH2 Q12809 2/20 0.39
CHRM2 P08172 1/20 0.38
CHRM3 P20309 1/20 0.38
OGA O60502 1/20 0.37
SCD O00767 1/20 0.37
IDH1 O75874 1/20 0.37
IDH2 P48735 1/20 0.37
SYK P43405 1/20 0.37
CCR5 P51681 1/20 0.37
WHR1 P49842 1/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199720 0.80 HRH3 (0.42) SLC6A7KDM4E
SCHEMBL1999730 0.78 SLC6A7 (0.46) SLC6A7RBP4PKMCHRM4LCAT
SCHEMBL5185106 0.77 METAP1 (0.48) PKMCHRM4HPGDCHRM3KDM4E
SCHEMBL17844147 0.74 GBA1 (0.35) IDH1IDH2WHR1
SCHEMBL17844241 0.73 MAPK10 (0.42)
SCHEMBL17844225 0.73 MAPK10 (0.42)
SCHEMBL5185355 0.70 CNR2 (0.42) PKMCHRM4HPGDKDM4E
SCHEMBL17844162 0.70 HRH3 (0.41) CHRM4LCATADRB1CCR2KCNH2
Hydrochloric Acid SCHEMBL17748980 0.69 ADRB1 (0.58) SLC6A7RBP4PKMCHRM4LCAT
SCHEMBL2328007 0.69 ADRB1 (0.54) SLC6A7RBP4PKMCHRM4LCAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016100619-A2 TREATMENT AND DIAGNOSIS OF CANCER RGENIX, INC. (US) 2016-06-23 WO disclosed
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed